| Literature DB >> 27236917 |
Marianna Madeo1, Michelle Stewart2, Yuyang Sun3, Nadia Sahir1, Sarah Wiethoff4, Indra Chandrasekar1, Anna Yarrow1, Jill A Rosenfeld5, Yaping Yang5, Dawn Cordeiro6, Elizabeth M McCormick7, Colleen C Muraresku7, Tyler N Jepperson1, Lauren J McBeth1, Mohammed Zain Seidahmed8, Heba Y El Khashab9, Muddathir Hamad10, Hamid Azzedine11, Karl Clark12, Silvia Corrochano2, Sara Wells2, Mariet W Elting13, Marjan M Weiss13, Sabrina Burn1, Angela Myers1, Megan Landsverk1, Patricia L Crotwell1, Quinten Waisfisz13, Nicole I Wolf14, Patrick M Nolan2, Sergio Padilla-Lopez15, Henry Houlden4, Richard Lifton16, Shrikant Mane16, Brij B Singh3, Marni J Falk7, Saadet Mercimek-Mahmutoglu6, Kaya Bilguvar16, Mustafa A Salih10, Abraham Acevedo-Arozena2, Michael C Kruer17.
Abstract
Glutamatergic neurotransmission governs excitatory signaling in the mammalian brain, and abnormalities of glutamate signaling have been shown to contribute to both epilepsy and hyperkinetic movement disorders. The etiology of many severe childhood movement disorders and epilepsies remains uncharacterized. We describe a neurological disorder with epilepsy and prominent choreoathetosis caused by biallelic pathogenic variants in FRRS1L, which encodes an AMPA receptor outer-core protein. Loss of FRRS1L function attenuates AMPA-mediated currents, implicating chronic abnormalities of glutamatergic neurotransmission in this monogenic neurological disease of childhood.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27236917 PMCID: PMC4908178 DOI: 10.1016/j.ajhg.2016.04.008
Source DB: PubMed Journal: Am J Hum Genet ISSN: 0002-9297 Impact factor: 11.025